This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

ACGL, Goldman: New Targets, Estimates

Also see: Citi, Peabody: Analysts' New Ratings

Editor's Note: Green and red arrows refer to intraday stock price movement.


Arch Capital (ACGL - Get Report) estimates were cut through 2011 at UBS. Reflects an increase of the second-quarter 2011 catastrophe loss estimate, UBS said. Maintain Neutral rating and $34 price target.

Cliffs Natural Resources (CLF - Get Report) estimates were increased through 2013 at UBS. Company announces phase III development of Bloom Lake, UBS said. Maintain Neutral rating and $34 price dtarget.

Campbell Soup (CPB - Get Report) estimates, target were raised at Goldman Sachs. Shares now seen reaching $34, and estimates were also increased, as a restructuring program was announced, Goldman said. Neutral rating.

Goldman Sachs (GS - Get Report) numbers were lowered through 2013 at Credit Suisse. Company is facing difficult market conditions, Credit Suisse said. Outperform rating and new $170 price target.

Harsco (HSC - Get Report) price target was cut at Jefferies to $38. Infrastructure business is still a work in progress, Jefferies said. Buy rating.

Maidenform (MFB) estimates, target were lowered at Citigroup. Shares now seen reaching $38. Estimates were also lowered, as sales have not been as robust as expected, Citigroup said. Buy rating.

Morgan Stanley (MS) numbers were reduced at Credit Suisse. Shares now seen reaching $33. Estimates also cut, given tougher market conditions, Credit Suisse said. Outperform rating.

Nike (NKE - Get Report) estimates, target raised at Citigroup. Shares now seen reaching $98, according to Citigroup. Estimates also increased on renewed apparel growth and innovation in footwear. Buy rating.

Progress Energy (PGN) target cut at Jefferies. Shares of PGN now seen reaching $48.50, according to Jefferies. Company could face delays at Crystal River, Jefferies said. Hold rating.

Rowan (RDC) estimates were cut through 2012 at UBS. Reflects closing of LTI sale and fleet status update. Maintain Buy rating and $50 price target.

Sigma Designs (SIGM) estimates, target were reduced at UBS. Shares now seen reaching $8.50. Estimates also lowered on IPTV segment recovery and sales mix uncertainties, UBS said. Maintain Neutral rating.

SYNNEX (SNX) estimates, target cut at Goldman Sachs. Shares now seen reaching $33. Estimates also lowered citing Japan weakness, Goldman said. Neutral rating.

Watson Pharmaceuticals (WPI) estimates, target raised at Morgan Stanley. Shares now seen reaching $78, according to Morgan Stanley. Estimates also increased on lower-than-expected royalties on Concerta and Specifar accretion, Morgan Stanley added. Overweight rating.

End of report.
This article was written by a staff member of TheStreet.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
MFB $23.50 0.04%
ACGL $65.94 -0.03%
CPB $55.84 0.90%
CLF $1.84 -4.66%
GS $156.47 -0.01%


Chart of I:DJI
DOW 16,204.97 -211.61 -1.29%
S&P 500 1,880.05 -35.40 -1.85%
NASDAQ 4,363.1440 -146.4150 -3.25%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs